Today: 11 June 2026
SoFi stock tumbles in regular session as post-upgrade bounce fades — what to watch next
4 February 2026
1 min read

SoFi stock tumbles in regular session as post-upgrade bounce fades — what to watch next

New York, Feb 4, 2026, 14:37 EST — Regular session

  • SoFi Technologies shares dropped roughly 6% in afternoon trading, wiping out gains from earlier in the day.
  • The move comes after J.P. Morgan upgraded the stock just a day ago, keeping attention fixed on the swings following earnings.
  • Next week’s delayed U.S. jobs report and inflation figures are on investors’ radar for any hints on rate moves.

Shares of SoFi Technologies, Inc. dropped Wednesday, shedding recent gains amid a wider retreat in growth and tech stocks that dampened investor sentiment.

SoFi slipped 6.4% to $20.37 by 2:24 p.m. EST, having reached a session peak of $21.88 earlier.

The decline is significant since SoFi has been behaving like a high-beta gauge of risk appetite, just days after releasing quarterly results that sparked both applause and doubt. The stock’s volatility has renewed focus on how fast the company can boost fee income while keeping credit costs in check if the economy slows down.

On Tuesday, J.P. Morgan raised SoFi’s rating to “Overweight” from “Neutral,” maintaining a $31 price target. The firm pointed to the post-earnings pullback as an attractive “entry point,” noting that the lender’s outlook and execution have alleviated some valuation concerns. Investing.com

Last week, SoFi posted a profit increase for the fourth quarter, driven by robust loan demand and quicker expansion in fee-based segments like financial services. CEO Anthony Noto told Reuters that member credit performance was “in line with expectations.” Reuters

Wednesday saw U.S. stocks drop, dragged down by steep declines in tech sectors, as investors wrestled with whether sky-high valuations remain justified amid growing concerns over competition and disruption. “The market is suddenly skeptical,” noted Jed Ellerbroek, portfolio manager at Argent Capital. Reuters

Separately, a Form 4 filing revealed that Chief Risk Officer Arun Pinto initiated a prepaid variable forward contract linked to 71,500 SoFi shares. He received roughly $1.2 million upfront and put up the shares as collateral. These contracts let executives unlock cash from their stock holdings while postponing the actual delivery of shares.

Analysts highlight SoFi’s growth in members and deposits as a standout amid fintech’s broader challenges with volatile demand and spotty funding.

That said, the situation can change fast. If charge-offs pick up again, consumer appetite for personal loans fades, or rate outlooks shift more abruptly than anticipated, earnings could come under strain — and the stock, already reactive to sentiment swings, would feel the impact.

Investors are now gearing up for key U.S. economic data that might shift the rates discussion. The Bureau of Labor Statistics announced the January employment report will drop Wednesday, Feb. 11. Then, the January CPI is scheduled for release Friday, Feb. 13.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Silicon Labs stock jumps on Texas Instruments’ $7.5 billion buyout deal at $231 a share
Previous Story

Silicon Labs stock jumps on Texas Instruments’ $7.5 billion buyout deal at $231 a share

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead
Next Story

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Go toTop